Covid-19 Saliva Screening Test Potential Market Outlook 2025-2034: Market Share, and Growth Analysis

The COVID-19 Saliva Screening Test Potential Market is valued at USD 5.1 billion in 2025 and is projected to grow at a CAGR of 8.6% to reach USD 10.7 billion by 2034.

The potential market for COVID-19 saliva screening tests has grown as researchers and healthcare providers seek non-invasive, user-friendly diagnostic methods. Saliva-based tests provide a more comfortable and accessible alternative to traditional nasopharyngeal swabs, making them especially appealing for large-scale testing in schools, workplaces, and public venues. This approach is not only less invasive but also reduces the risk of exposure for healthcare workers, as it can often be self-administered. As a result, the saliva screening test market has gained attention from both public health agencies and private companies looking to expand testing accessibility.

The market witnessed continued investment in saliva-based diagnostics. Several startups and established biotech firms developed rapid saliva tests that deliver results in under an hour. Governments supported these initiatives by funding research and fast-tracking regulatory approvals. Meanwhile, universities and corporate campuses increasingly relied on saliva testing to monitor and contain outbreaks. Innovations included portable, smartphone-connected devices that analyze saliva samples on-site, offering a blend of convenience and accuracy. These advancements positioned saliva screening as a critical tool in the ongoing battle against COVID-19, particularly as variant detection became a priority.

The COVID-19 saliva screening test market is likely to diversify. Companies are exploring ways to integrate saliva testing into broader health monitoring platforms, potentially enabling individuals to track multiple health metrics through a single sample. Additionally, as global vaccination campaigns reduce severe cases, demand for convenient, repeatable screening methods will persist for routine surveillance and travel requirements. The continued development of more accurate and cost-effective saliva tests, combined with their inherent ease of use, will solidify their role in public health strategies and pandemic preparedness plans.

Key Insights: COVID-19 Saliva Screening Test Potential Market

• Rising adoption of saliva-based testing due to its non-invasive nature.
• Development of rapid, portable saliva testing devices.
• Integration of saliva tests with digital health platforms and mobile applications.
• Focus on detecting multiple COVID-19 variants and other respiratory pathogens.
• Expansion of saliva testing into routine workplace and school screening programs.

• Increased preference for non-invasive diagnostic methods.
• Growing need for convenient, repeatable testing solutions.
• Continued funding and regulatory support for innovative saliva-based diagnostics.
• Technological advancements enabling faster and more accurate results.

• Maintaining consistent sensitivity and specificity across different saliva test platforms.
• Logistical hurdles in scaling production and distribution globally.
• Navigating a competitive landscape with numerous diagnostic alternatives.

COVID-19 Saliva Screening Test Potential Market Segmentation

By Location

• Travel Stations
• Sports Arenas
• Entertainment Venues
• Corporate Campus Environments
• Universities and Colleges
• Factories
• Other Locations

By Technology

• Fluorescence-Labelled Antigen
• RT-PCR
• CRISPR-Cas9)
• By Mode of Testing (Centralized Testing
• Decentralized Testing

Key Companies Analysed

• Roche Diagnostics Corporation
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• Danaher Corporation
• University of North Carolina at Chapel Hill
• Hologic Inc.
• Beaumont Health
• PerkinElmer Inc.
• Quidel Corporation
• University of Illinois at Urbana-Champaign
• Cepheid
• Seegene Inc.
• ARUP Laboratories
• Vatic Health Limited
• Ambry Genetics Corporation
• LumiraDx Ltd.
• Yale School of Public Health
• Gravity Diagnostics
• Psomagen Inc.
• Fluidigm Corporation
• Phosphorus Diagnostics LLC
• DxTerity Diagnostics Inc.
• University of Notre Dame
• MOgene
• FLuroTech Ltd.

COVID-19 Saliva Screening Test Potential Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

COVID-19 Saliva Screening Test Potential Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

• North America - COVID-19 Saliva Screening Test Potential market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - COVID-19 Saliva Screening Test Potential market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • BeNeLux
  • Russia
  • Sweden
  
  
• Asia-Pacific - COVID-19 Saliva Screening Test Potential market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - COVID-19 Saliva Screening Test Potential market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - COVID-19 Saliva Screening Test Potential market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru

Research Methodology

This study combines primary inputs from industry experts across the COVID-19 Saliva Screening Test Potential value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

• What is the current and forecast market size of the COVID-19 Saliva Screening Test Potential industry at global, regional, and country levels?
• Which types, applications, and technologies present the highest growth potential?
• How are supply chains adapting to geopolitical and economic shocks?
• What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
• Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
• Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
• Where are the most investable opportunities - across technology roadmaps, sustainability-linked innovation, and M&A - and what is the best segment to invest over the next 3-5 years?

Your Key Takeaways from the COVID-19 Saliva Screening Test Potential Market Report

• Global COVID-19 Saliva Screening Test Potential market size and growth projections (CAGR), 2024-2034
• Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on COVID-19 Saliva Screening Test Potential trade, costs, and supply chains
• COVID-19 Saliva Screening Test Potential market size, share, and outlook across 5 regions and 27 countries, 2023-2034
• COVID-19 Saliva Screening Test Potential market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
• Short- and long-term COVID-19 Saliva Screening Test Potential market trends, drivers, restraints, and opportunities
• Porter’s Five Forces analysis, technological developments, and COVID-19 Saliva Screening Test Potential supply chain analysis
• COVID-19 Saliva Screening Test Potential trade analysis, COVID-19 Saliva Screening Test Potential market price analysis, and COVID-19 Saliva Screening Test Potential supply/demand dynamics
• Profiles of 5 leading companies - overview, key strategies, financials, and products
• Latest COVID-19 Saliva Screening Test Potential market news and developments

Additional Support

With the purchase of this report, you will receive:

• An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
• Complimentary report update to incorporate the latest available data and the impact of recent market developments.

This product will be delivered within 1-3 business days.